SEO Test Tool

This tool allows you to analyze the source code of a page
and verify the optimization for the search engines.


Respuesta: HTTP/1.1 200 OK
Date: Tue, 26 May 2020 16:18:43 GMT
Server: Zope/(2.13.22, python 2.7.13, linux2) ZServer/1.1
X-Frame-Options: SAMEORIGIN
Access-Control-Allow-Origin: *
Content-Type: text/html; charset=utf-8
Content-Length: 5899
X-Varnish: 148740385
Age: 0
Via: 1.1 varnish (Varnish/5.0)
X-Cache: MISS
Accept-Ranges: bytes
Set-Cookie: ANONSERVERID=app-anon-4.haiku.fry=c2; path=/
Via: 1.0
Vary: Accept-Encoding
Strict-Transport-Security: max-age=15768000
Connection: close
Texto: × Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia. Arezes J., Foy N., McHugh K., Quinkert D., Benard S., Sawant A., Frost JN., Armitage AE., Pasricha S-R., Lim PJ., Tam MS., Lavallie E., Pittman DD., Cunningham O., Lambert M., Murphy JE., Draper SJ., Jasuja R., Drakesmith H. Erythroferrone (ERFE) is produced by erythroblasts in response to erythropoietin (EPO) and acts in the liver to prevent hepcidin stimulation by BMP6. Hepcidin suppression allows for the mobilization of iron to the bone marrow for the production of red blood cells. Aberrantly high circulating ERFE in conditions of stress erythropoiesis, such as in patients with β-thalassemia, promotes the tissue iron accumulation that substantially contributes to morbidity in these patients. Here we developed antibodies against ERFE to prevent hepcidin suppression and to correct the iron loading phenotype in a mouse model of β-thalassemia [Hbb(th3/+) mice] and used these antibodies as tools to further characterize ERFE's mechanism of action. We show that ERFE binds to BMP6 with nanomolar affinity and binds BMP2 and BMP4 with somewhat weaker affinities. We found that BMP6 binds the N-terminal domain of ERFE, and a polypeptide derived from the N terminus of ERFE was sufficient to cause hepcidin suppression in Huh7 hepatoma cells and in wild-type mice. Anti-ERFE antibodies targeting the N-terminal domain prevented hepcidin suppression in ERFE-treated Huh7 cells and in EPO-treated mice. Finally, we observed a decrease in splenomegaly and serum and liver iron in anti-ERFE-treated Hbb(th3/+) mice, accompanied by an increase in red blood cells and hemoglobin and a decrease in reticulocyte counts. In summary, we show that ERFE binds BMP6 directly and with high affinity, and that antibodies targeting the N-terminal domain of ERFE that prevent ERFE-BMP6 interactions constitute a potential therapeutic tool for iron loading anemias. DOI 10.1182/blood.2019003140 Type Journal article Journal Blood Publication Date 20/02/2020 Volume 135 Pages 547 - 557 Permalink Original publication


Otras páginas de analisis SEO :   Woorank en español - Pages Inventory SEO tool - Seo book - Seo Site Checkup

Valid XHTML 1.0 Transitional ¡CSS Válido!